Cargando…
Up‐regulation of HDACs, a harbinger of uraemic endothelial dysfunction, is prevented by defibrotide
Endothelial dysfunction is an earlier contributor to the development of atherosclerosis in chronic kidney disease (CKD), in which the role of epigenetic triggers cannot be ruled out. Endothelial protective strategies, such as defibrotide (DF), may be useful in this scenario. We evaluated changes ind...
Autores principales: | Palomo, Marta, Vera, Manel, Martin, Susana, Torramadé‐Moix, Sergi, Martinez‐Sanchez, Julia, Belen Moreno, Ana, Carreras, Enric, Escolar, Ginés, Cases, Aleix, Díaz‐Ricart, Maribel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991634/ https://www.ncbi.nlm.nih.gov/pubmed/31782253 http://dx.doi.org/10.1111/jcmm.14865 |
Ejemplares similares
-
Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
por: Diaz-Ricart, Maribel, et al.
Publicado: (2020) -
Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
por: Martinez-Sanchez, Julia, et al.
Publicado: (2019) -
Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response
por: Martinez‐Sanchez, Julia, et al.
Publicado: (2023) -
NFκB in the Development of Endothelial Activation and Damage in Uremia: An In Vitro Approach
por: Caballo, Carolina, et al.
Publicado: (2012) -
Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
por: Castro, Pedro, et al.
Publicado: (2021)